培米替尼靶向药价格，培米替尼多少钱？

It is a potent and selective oral FGFR1~FGFR3 inhibitor. It is currently the world's first and only cholangiocarcinoma (CCA) targeted drug approved by the US FDA. The drug was developed by Incyte Genomics, a well-known global biopharmaceutical company in the United States. In April 2020, it was approved for the treatment of adult advanced cCA (especially adult patients with previously treated, locally advanced or metastatic cCA that contains FGFR2 fusion or rearrangement and is unresectable).

Common side effects of pemetinib: stomach pain, mouth sores, rapid heartbeat, weight loss, constipation, dry mouth and/or dry skin, onychomycosis, joint pain, painful urination, diarrhea, decreased urine output, taste changes, vomiting, nausea, loss of appetite, hair loss, headache, fatigue, swelling and pain in limbs or joints. When patients use pemetinib, they must strictly follow the doctor's instructions and take the medication correctly to maximize the effect of pemetinib. During the medication period, patients must not increase or decrease the dose of the drug by themselves. Pemetinib will not improve the therapeutic effect just because the dose of the drug is increased, so do not use the drug blindly.

The price of pemetinib targeted drug, how much is the Indian version of pemetinib? Pemetinib is not yet available on the market in China, so many patients in China have been unable to seek treatment, but are in desperate need of treatment with this drug. At this time, more patients chose other versions of pemetinib for treatment. Although the Indian version of pemetinib is a generic drug, its efficacy is very resistant and has the same therapeutic effect as the original drug, so patients can use it with confidence. However, since the drug is purchased overseas, the price of the drug is closely related to the exchange rate, so it is not fixed. For details, you can consult Medical Companion Travel and we will answer your questions wholeheartedly.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.